VCAM-1 and ICAM-1 mediate leukocyte-endothelial cell adhesion in rat experimental colitis
Summary
This summary is machine-generated.Vascular cell adhesion molecule 1 (VCAM-1) is upregulated in experimental colitis, driving leukocyte recruitment. Blocking VCAM-1 significantly reduces inflammation and leukocyte adhesion in the inflamed intestine.
Area Of Science
- Gastroenterology
- Immunology
- Cell Biology
Background
- Leukocyte recruitment mechanisms in experimental colitis remain unclear.
- Understanding these mechanisms is crucial for developing targeted therapies.
Purpose Of The Study
- To measure endothelial intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) expression in experimental colitis.
- To determine the role of ICAM-1 and VCAM-1 in leukocyte recruitment during colitis.
Main Methods
- Trinitrobenzene sulfonic acid (TNBS)-induced colitis model in rats.
- Quantification of ICAM-1 and VCAM-1 expression using radiolabeled antibodies.
- In vivo assessment of leukocyte-endothelial cell interactions via intravital microscopy.
- Evaluation of therapeutic efficacy using anti-VCAM-1 antibodies.
Main Results
- VCAM-1 expression significantly increased in colitic rats, correlating with disease severity and leukocyte adhesion.
- ICAM-1 was constitutively expressed and did not increase with colitis.
- Immunoneutralization of VCAM-1 abrogated leukocyte adhesion and attenuated colitis.
- Anti-ICAM-1 antibodies partially reduced leukocyte adhesion.
Conclusions
- Endothelial VCAM-1 is upregulated during TNBS-induced colitis.
- VCAM-1 and constitutive ICAM-1 are key mediators of leukocyte recruitment in inflamed intestines.
- Targeting VCAM-1 offers a potential therapeutic strategy for colitis.
View abstract on PubMed